Lannett Company Management

Arthur P. Bedrosian, J.D. was elected President of the Company in May 2002 and CEO in January of 2006. Prior to this, he served as the Company's Vice President of Business Development from January 2002 to April 2002, and as a Director from February 2000 to January 2002. Mr. Bedrosian has operated generic drug manufacturing, sales, and marketing businesses in the healthcare industry for many years. Prior to joining the Company, from 1999 to 2001, Mr. Bedrosian served as President and Chief Executive Officer of Trinity Laboratories, Inc., a medical device and drug manufacturer. Mr. Bedrosian also operated Pharmaceutical Ventures Ltd, a healthcare consultancy and Interal Corporation, a computer consultancy to Fortune 100 companies. Mr. Bedrosian holds a Bachelor of Arts Degree in Political Science from Queens College of the City University of New York and a Juris Doctorate from Newport University in California.

Michael Bogda, 53, joined the Company as President, in December 2014. Prior to this, Mr. Bogda served as Teva Pharmaceuticals’ Executive Vice President Americas Technical Operations from 2011 to 2014 and Executive Vice President US Technical Operations from 2009 to 2011, overseeing production, sourcing and supply chain, among other responsibilities. Before that, he held a number of positions of increasing responsibility for Barr Pharmaceuticals from 2000 to 2008, rising to President and Chief Operating Officer. Prior to his tenure at Barr Pharmaceuticals, Mr. Bogda served as Vice President Operations for Copley Pharmaceuticals. He earned a Master of Business Administration Degree from the Wharton School of the University of Pennsylvania, and a Master of Science degree in Chemical Engineering and a Bachelor of Science degree in Chemical Engineering from Rutgers University.

Kevin Smith joined the Company in January 2002 as Vice President of Sales and Marketing. Prior to this, from 2000 to 2001, he served as Director of National Accounts for Bi-Coastal Pharmaceutical, Inc., a pharmaceutical sales representation company. Prior to this, from 1999 to 2000, he served as National Accounts Manager for Mova Laboratories Inc., a pharmaceutical manufacturer. Prior to this, from 1991 to 1999, Mr. Smith served as National Sales Manager at Sidmak Laboratories, a pharmaceutical manufacturer. Mr. Smith has extensive experience in the generic sales market, and brings to the Company a vast network of customers, including retail chain pharmacies,wholesale distributors, mail-order wholesalers and generic distributors. Mr. Smith has a Bachelor of Science Degree in Business Administration from Gettysburg College.

Martin P. Galvan, CPA was appointed as the Company’s Vice President of Finance and Chief Financial Officer in August 2011. Most recently, he was Chief Financial Officer of CardioNet, Inc., a medical technology and service company. From 2001 to 2007, Mr. Galvan was employed by Viasys Healthcare Inc., a healthcare technology company that was acquired by Cardinal Health, Inc. in June 2007. Prior to the acquisition, he served as Executive Vice President, Chief Financial Officer and Director Investor Relations. From 1999 to 2001, Mr. Galvan served as Chief Financial Officer of Rodel, Inc., a precision surface technologies company in the semiconductor industry. From 1979 to 1998, Mr. Galvan held several positions with Rhone-Poulenc Rorer Inc., a pharmaceutical company, including Vice President, Finance - The Americas; President & General Manager, RPR Mexico & Central America; Vice President, Finance, Europe/Asia Pacific; and Chief Financial Officer, United Kingdom & Ireland. Mr. Galvan began his career with the international accounting firm Ernst & Young LLP. He earned a Bachelor of Arts degree in economics from Rutgers University and is a member of the American Institute of Certified Public Accountants.

John M. Abt joined the Company as Vice President of Quality, effective March 30, 2015. Prior to joining Lannett, Mr. Abt served as Teva Pharmaceuticals’ Vice President of Global Quality Strategy from 2012 to 2015 where he oversaw the development and implementation of global quality operating plans, standardization and efficiency programs and off shoring efforts. Prior to that he served as the Teva’s Vice President of North America Quality Systems and Compliance from 2009 to 2012 where he was responsible for ensuring compliance of North American production and global supply sites with FDA regulations via the development and execution of effective quality systems. From 2004 to 2009 Mr. Abt was the Vice President of US Operations for Teva overseeing production, engineering, and the integration of acquired facilities among other responsibilities after serving as the Plant Manager of the Teva Sellersville Plant from 2000-2004. Before that, he held a number of quality positions of increasing responsibility at Alpharma from 1988-2000. He earned a Master of Administration Sciences Degree in Management from Johns Hopkins University and his BS in Biochemistry from Niagara University in NY.

Mahendra Dedhiya, Ph.D., joined the Company in June 2015 as Vice President of Scientific Affairs. Prior to this, from 2014 to 2015, he served as Executive Vice President of Scientific Affairs for Silarx Pharmaceuticals (acquired by Lannett in June 2015). Prior to this, from 2001 to 2014, he held a number of senior management positions at Forest Laboratories. Earlier, from 1989 to 2000, Dr. Dedhiya served as Director of Product Development at Roxane Laboratories, and before that, from 1978 to 1988, was Director at Bayer. He earned a doctorate degree in Pharmaceutics from the University of Michigan, a master degree in Medicinal Chemistry from the University of Rhode Island, a master of business administration (MBA) degree from the University of Bridgeport and a bachelor degree from University of Poona.

Robert Ehlinger, joined the Company in July 2006 as their Chief Information Officer. In June 2011, Mr. Ehlinger was promoted to Vice President of Logistics and Chief Information Officer. Prior to joining Lannett, Mr. Ehlinger was the Vice President of Information Technology at MedQuist, Inc., a healthcare services provider, where his career spanned 10 years in progressive operational and technology roles. Prior to MedQuist, Mr. Ehlinger was with Kennedy Health Systems as their Corporate Director of Information Technology supporting acute care and ambulatory care health information systems and biomedical support services. Earlier on, Mr. Ehlinger was with Dowty Communications where he held various technical and operational support roles prior to assuming the role of International Distribution Sales Executive managing the Latin America sales distribution channels. Mr. Ehlinger received a Bachelor’s of Arts degree in Physics from Gettysburg College in Gettysburg, PA.

about Lannett Company
about Lannett Company
Letter to Shareholders

Arthur P. Bedrosian discusses the Fiscal 2017 results.
Read, Print or Download the full letter.

Corporate Leadership

View the biographies of Lannett's Corporate Leadership:
Senior Management
Board of Directors

Community Relations

Our dedicated employees strive to position Lannett as an industry leader that is focused on quality and integrity, as well as giving back to the community we serve. Read More.

Career Opportunities

Interested in joining the Lannett team?
Search our current opportunities
Or submit your resume online

about Lannett Company